FORM 6-K
 

 

SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549

 

Report of Foreign Issuer

 

Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
 


For period ending August 28, 2008
 

GlaxoSmithKline plc
(Name of registrant)
 
 

 

980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address of principal executive offices)
 
 

Indicate by check mark whether the registrant files or
will file annual reports under cover Form 20-F or Form 40-F
 
 

Form 20-F x Form 40-F
 

 --

Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
 
 
Yes No x
  --

 

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in interests in the 
Ordinary share ADRs
 
of GlaxoSmithKline plc in respect
 of the under-mentioned Person
 Discharging Managerial Responsibility
:-

Mr 
D J Phelan
Sale
 of 
5,000 ADR shares on 
25 August
 2008
 at a price
of 
$46.08
 
per 
ADR
 share


Sale of 6,090 ADR shares on 
25 August 2008
 at a price of
$46.01 
per 
ADR
 share
 



The Company was advised of t
his transaction
 on
 
28 August
 2008
.

This notification is in accordance with 
Disclosure Rule 
3.1.4R(1)(a
)
.

 
S M Bicknell
Company Secretary

28 August 
2008

 

SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
 
 

GlaxoSmithKline plc
(Registrant)
 
 

Date:  August 28, 2008

By: VICTORIA WHYTE

------------------

Victoria Whyte
Authorised Signatory for and on
behalf of GlaxoSmithKline plc